These 6 stocks stand to deliver gains. Here’s why.
Read MorePlus, another 2.4 million Americans filed for unemployment bringing the pandemic total to more than 38 million, AstraZeneca was awarded $1.2 billion from the U.S. government for the development of its COVID-19 vaccine, and Best Buy shares are down after earnings.
Read MoreBuy Price: $51.00 or better Sell Price: TradersPro Sell Signal Applied Therapeutics, Inc., a biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that is in phase I/II for the treatment of galactosemia; AT-001 that is in phase II clinical trials for treating diabetic cardiomyopathy, […]
Read MorePlus, Moderna shares are down after a report throwing cold water on its preliminary vaccine results, doctors in China are seeing the coronavirus manifest differently in a second wave of infections, Google Cloud landed a new contract with the DoD, and Lowe’s reported online sales surged 80% in its first quarter.
Read MorePlus, Trump threatened to permanently halt funding to the World Health Organization, major tech executives sent a letter to Congress urging another $1 trillion in relief for state and local governments, airlines are seeing bookings rise, and Pier 1 is seeking approval to wind down its business completely.
Read MorePlus, Fed Chairman Powell said the U.S. economy could shrink 30% in the second quarter, oil surged to a two-month high, and FedEx and Microsoft are teaming up to “transform commerce” with a new data service.
Read MorePlus, JCPenney is expected to file for bankruptcy today, the Trump administration moved to block chip shipments to Huawei, and the FDA issued a warning about Abbott Labs’ rapid COVID-19 test.
Read MoreThis sector has been surging lately, and one trader just placed a big wager that the group will continue to climb.
Read MorePlus, weekly jobless claims came it at just under 3 million and Goldman Sachs says the unemployment rate could peak at 25%, Trump said he doesn’t want to talk to Chinese President Xi as tensions rise between the world’s two largest economies, and airlines are down after a trade group said demand for air travel is unlikely to recover until 2023.
Read MoreBuy Price: $2.25 or better Sell Price: TradersPro Sell Signal Cleveland BioLabs, Inc., a biopharmaceutical company, develops novel approaches to activate the immune system and address various medical needs in the United States and Russia. Its proprietary platform of toll-like immune receptor activators (TLR) has applications in mitigation of radiation injury, radiation oncology, and vaccines.
Read MorePlus, House Democrats unveiled their latest coronavirus relief bill, Sanofi said the U.S. will get its COVID-19 vaccine before the rest of the world if successful, JCPenney is talking with lenders ahead of an expected bankruptcy filing, and Tesla won its battle to start reopening its Fremont, CA plant.
Read MorePlus, the FDA granted emergency use authorization for Abbott Laboratories’ COVID-19 antibodies test, oil is higher after Saudi Arabia said it would cut production by an additional 1 million barrels per day, and Constellation Brands got a downgrade from MKM Partners.
Read MoreBuy Price: $14.75 or better Sell Price: TradersPro Sell Signal Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies using protein design technology. The company’s lead product candidate is NL-201, a computationally-designed de novo protein therapeutic for the treatment of IL-2/IL-15 cancer immunotherapy. It also engages in research activities for the treatment of autoimmunity and allergy.
Read MorePlus, Sorrento Therapeutics is partnering with New York’s Mount Sinai on developing a antibody cocktail to shield health care workers and other front-line workers from the coronavirus, Tesla is resuming production at its Fremont, CA plant, and Disney shares got a boost from tickets selling out within minutes for the reopening of its Shanghai Disneyland park.
Read MoreBuy Price: $96 or better Sell Price: TradersPro Sell Signal Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing novel therapies for central nervous system (CNS) disorders in the United States. Its product pipeline includes AXS-05, which is in the phase III clinical trial for the treatment resistant depression and depressive disorders; and […]
Read More